back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-08-30 13:46 Tx date 2022-12-21 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
57 - Exercise of rights
|
$23,250
+50,000 vol $0.465 each |
1,358,369 | |
| Filed 2022-12-21 13:53 Tx date 2022-12-21 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
57 - Exercise of rights
|
$2,500,000,000
+50,000 vol $50,000 each |
||
| Filed 2023-03-17 10:07 Tx date 2023-03-15 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$66,000
+100,000 vol $0.66 each |
300,000 | |
| Filed 2023-01-29 10:41 Tx date 2023-01-27 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
56 - Grant of rights
|
$21,000
+37,500 vol $0.56 each |
37,500 | |
| Filed 2023-01-29 10:39 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-12-21 13:53 Tx date 2022-12-21 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
57 - Exercise of rights
|
$2,500,000,000
+50,000 vol $50,000 each |
1,358,369 | |
| Filed 2022-12-21 13:52 Tx date 2022-12-21 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
57 - Exercise of rights
|
-50,000 vol |
0 | |
| Filed 2022-05-02 12:17 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
200,000 | |
| Filed 2021-05-26 08:43 Tx date 2021-05-25 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
56 - Grant of rights
|
$56,000
+50,000 vol $1.12 each |
50,000 | |
| Filed 2021-05-26 08:41 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-02 13:38 Tx date 2020-06-30 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+175,000 vol |
175,000 | |
| Filed 2020-07-02 13:37 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-04 Tx date 2018-12-27 |
$
VALEO PHARMA INC. |
Therrien, Nathalie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
1,308,369 |